PEN
Price:
$240.36
Market Cap:
$9.22B
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for ...[Read more]
Industry
Medical - Devices
IPO Date
2015-09-18
Stock Exchange
NYSE
Ticker
PEN
According to Penumbra, Inc.’s latest financial reports and current stock price. The company's current ROE is 2.97%. This represents a change of 296.05% compared to the average of 0.75% of the last 4 quarters.
The mean historical ROE of Penumbra, Inc. over the last ten years is 0.59%. The current 2.97% ROE has changed 402.80% with respect to the historical average. Over the past ten years (40 quarters), PEN's ROE was at its highest in in the December 2023 quarter at 4.60%. The ROE was at its lowest in in the June 2024 quarter at -5.18%.
Average
0.59%
Median
1.09%
Minimum
-18.15%
Maximum
9.97%
Discovering the peaks and valleys of Penumbra, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 537.93%
Maximum Annual ROE = 9.97%
Minimum Annual Increase = -3949.18%
Minimum Annual ROE = -18.15%
Year | ROE | Change |
---|---|---|
2023 | 7.71% | -3949.18% |
2022 | -0.20% | -172.89% |
2021 | 0.27% | -109.16% |
2020 | -3.00% | -130.10% |
2019 | 9.97% | 537.93% |
2018 | 1.56% | 34.41% |
2017 | 1.16% | -79.07% |
2016 | 5.56% | 446.43% |
2015 | 1.02% | -105.60% |
2014 | -18.15% | -64.30% |
The current ROE of Penumbra, Inc. (PEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.60%
5-year avg
2.95%
10-year avg
0.59%
Penumbra, Inc.’s ROE is less than ShockWave Medical, Inc. (0%), less than Insulet Corporation (24.79%), less than TransMedics Group, Inc. (46.26%), less than Masimo Corporation (18.74%), less than Inspire Medical Systems, Inc. (5.65%), less than Inari Medical, Inc. (5.30%), greater than InMode Ltd. (-17.75%), less than Tandem Diabetes Care, Inc. (19.89%), greater than DexCom, Inc. (-49.32%), less than Integer Holdings Corporation (31.20%), less than CONMED Corporation (7.30%), less than LivaNova PLC (15.04%), less than iRhythm Technologies, Inc. (1.88%), greater than Heska Corporation (-127.85%), greater than null (-4.29%),
Company | ROE | Market cap |
---|---|---|
0% | $12.57B | |
24.79% | $18.46B | |
46.26% | $2.14B | |
18.74% | $9.01B | |
5.65% | $5.58B | |
5.30% | $3.14B | |
-17.75% | $1.44B | |
19.89% | $2.43B | |
-49.32% | $31.34B | |
31.20% | $4.52B | |
7.30% | $2.16B | |
15.04% | $2.54B | |
1.88% | $2.80B | |
-127.85% | $1.31B | |
-4.29% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Penumbra, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Penumbra, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Penumbra, Inc.'s ROE?
How is the ROE calculated for Penumbra, Inc. (PEN)?
What is the highest ROE for Penumbra, Inc. (PEN)?
What is the 3-year average ROE for Penumbra, Inc. (PEN)?
What is the 5-year average ROE for Penumbra, Inc. (PEN)?
How does the current ROE for Penumbra, Inc. (PEN) compare to its historical average?